Sanofi Consumer Healthcare India Ltd Q3 FY26 Results
SANOFICONRQ3 FY26 ResultsAnnounced 25 Feb, 7:01 pm| Metric | Value (₹ Cr) | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Revenue | 251.00 | 7.3% | 65.4% |
| Total Income | 255.60 | 7.9% | 65.3% |
| Expenditure | 165.10 | 8.1% | 64.3% |
| PBT | 90.50 | 7.6% | 63.3% |
| Net Profit | 66.50 | 5.7% | 63.3% |
| OPM | 35.78% | 0.56pp | 4.67pp |
| NPM | 26.02% | 0.53pp | 1.48pp |
| EPS | 28.87 | 5.7% | 63.3% |
Sanofi Consumer Healthcare India Ltd Reports Q4’25 Revenue at 2,510 MN, Up by 47%, Net Profit at 665 MN, Up by 50%
25 Feb 2026 · 25 Feb, 8:32 pm
Summary
Sanofi Consumer Healthcare India Limited reported financial updates for Q4 & FY 2025.
Key Highlights
- 1
rev: 2,510
- 2
rev yoy: 47%
- 3
pat: 665
- 4
pat yoy: 50%
Management Comments
Himanshu Bakshi
This quarter’s performance emphasizes the strength of our core portfolio and the disciplined execution of our growth agenda. Our domestic business has delivered healthy double-digit growth for two successive quarters, complemented by strong contributions from our export markets. The recognition we’ve earned for elevating our brands and championing the issues Qa nofi Sanofi Consumer Healthcare India Limited o SANOFI CONSUMER HEALTHCARE INDIA LIMITED q a n o fl o that matter to consumers is a testament to our teams’ commitment. As we continue to invest in our people and our brands, we remain focused on reinforcing our brand fundamentals and driving operational excellence to unlock the next phase of sustainable growth. Guided by science and driven by purpose, we remain committed to simplifying self-care, making it more accessible and effective for every consumer.”
Amit Jain
Our full-year performance reflects the strength of our strategy and the disciplined execution by our teams. By driving sustained growth, deepening penetration of our portfolio and accelerating digital transformation, we delivered meaningful outcomes for all our stakeholders. Our strong financial performance this year enables us to reward shareholders with a healthy dividend of ¥75 per share.”
Informational and educational content only. Not investment advice.